Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I molecules

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 532-538

  Fu, Jie ^a   Bouvier, Marlene ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Adenovirus; Antigen presentation; E3 19K; Immune evasion mechanisms; Immunomodulatory proteins; MHC class I molecules; Persistent viruses

Indexed keywords

ADENOVIRUS 2 PROTEIN E3 19K PROTEIN; AMINO ACID; HISTIDINE; HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT PROTEIN; TYROSINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS 2; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; COMPARATIVE STUDY; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; IMMUNOMODULATION; IMMUNOPATHOLOGY; NATIVE GEL BAND SHIFT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; SITE DIRECTED MUTAGENESIS;

ADENOVIRUS E3 PROTEINS; AMINO ACID SEQUENCE; AMINO ACIDS; CHYMOTRYPSIN; CONSERVED SEQUENCE; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HUMANS; IMMUNOMODULATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SOLUTIONS; STRUCTURE-ACTIVITY RELATIONSHIP; TYROSINE;

ADENOVIRIDAE;

EID: 78650613873     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.10.017     Document Type: Article

References (33)

1. Andersson M., McMichael A., Peterson P.A. Reduced allorecognition of adenovirus-2 infected cells. J. Immunol. 1987, 13:3960-3966.
2. Beier D.C., Cox J.H., Vining D.R., Cresswell P., Engelhard V.H. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 1994, 152:3862-3872.
3. Bouvier M., Wiley D.C. Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/β2m heterodimer. Nat. Struct. Biol. 1998, 5:377-384.
4. Burgert H.-G., Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 1985, 41:987-997.
5. Burgert H.-G., Kvist S. The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J. 1987, 6:2019-2026.
6. Burgert H.-G., Maryanski J.L., Kvist S. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:1356-1360.
7. Burgert H.-G. Subversion of the MHC class I antigen-presentation pathway by adenovirus and herpes simplex virus. Trends Microbiol. 1996, 4:107-112.
8. Cox J.H., Yewdell J.W., Eisenlohr L.C., Johnson P.R., Bennink J.R. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 1990, 247:715-718.
9. Cox J.H., Bennink J.R., Yewdell J.W. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 1991, 174:1629-1637.
10. Deryckere F., Burgert H.-G. Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroup B and C. J. Virol. 1996, 70:2832-2841.
11. Feuerbach D., Etteldorf S., Ebenau-Jehle C., Abastado J.-P., Madden D., Burgert H.-G. Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K. J. Immunol. 1994, 153:1626-1636.
12. Flomenberg P., Szmulewicz J., Gutierrez E., Lupatkin H. Role of the adenovirus E3-19K conserved region in binding major histocompatibility complex class I molecules. J. Virol. 1992, 66:4778-4783.
13. Flomenberg P., Gutierrez E., Hogan K.T. Identification of class I MHC regions which bind to the adenovirus E3-19K protein. Mol. Immunol. 1994, 31:1277-1284.
14. Flomenberg P., Piaskowski V., Truitt R.L., Casper J.T. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J. Virol. 1996, 70:6314-6322.
15. Fontana A., de Laureto P.P., Spolaore B., Frare E., Picotti P., Zambonin M. Probing protein structure by limited proteolysis. Acta Biochim. Pol. 2004, 511:299-321.
16. Gabathuler R., Levy F., Kvist S. Requirement for the association of adenovirus type 2 E3-19K wild-type and mutant proteins with HLA antigens. J. Virol. 1990, 64:3679-3685.
17. Garboczi D.N., Hung D.T., Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:3429-3433.
18. Ginsberg H.S., Lundholm-Beauchamp U., Horswood R.L., Pernis B., Wold W.S., Chanock R.M., Prince G.A. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:3823-3827.
19. Green M., Mackey J., Wold W., Rigden P. Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies. Virology 1979, 93:481-492.
20. Hansen T.H., Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 2009, 9:503-513.
21. Hermiston T.W., Tripp R.A., Sparer T., Gooding L.R., Wold W.S.M. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I. antigen binding protection from adenovirus-specific cytotoxic T lymphocytes. J. Virol. 1993, 67:5289-5298.
22. Horwitz M.S. Adenoviridae. Fields Virology 1990, 1723-1740. Raven Press, New York, NY. 2nd ed. D.N. Fields, D.M. Knipe (Eds.).
23. Kvist S., Ostberg L., Persson H., Philipson L., Peterson P.A. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:5674-5678.
24. Liu H., Stafford W.F., Bouvier M. The endoplasmic reticulum lumenal domain of the adenovirus type 2 E3-19K binds to peptide-filled and peptide-deficient HLA-A*1101 molecules. J. Virol. 2005, 79:13317-13325.
25. Liu H., Fu J., Bouvier M. Allele- and locus-specific recognition of class I MHC molecules by the immunomodulatory E3-19K protein from adenovirus. J. Immunol. 2007, 178:4567-4575.
26. Pääbo S., Nilsson T., Peterson P.A. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:9665-9669.
27. Pääbo S., Weber F., Wilson T., Schaffner W., Peterson P.A. Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J. 1986, 5:1921-1927.
28. Pääbo S., Bhat B.M., Wold W.S.M., Peterson P.A. A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 1987, 50:311-317.
29. Rawle F.C., Tollefson A.E., Wold W.S.M., Gooding L.R. Mouse anti-adenovirus cytoxic T lymphocytes. J. Immunol. 1989, 138:3960-3966.
30. Sester M., Koebernick K., Owen D., Ao M., Bromberg Y., May E., Stock E., Andrews L., Groh V., Spies T., Steinle A., Menz B., Burgert H.-G. Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteins. J. Immunol. 2010, 184:255-257.
31. Toth K., Kuppuswamy M., Doronin K., Doronin O.A., Lichtenstein D.L., Tollefson A.E., Wold W.S.M. Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region. Virology 2002, 301:99-108.
32. Wadell G. Molecular epidemiology of human adenoviruses. Curr. Top. Microbiol. Immunol. 1984, 110:191-220.
33. Wold W.S.M., Gooding L.R. Adenovirus region of E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol. Biol. Med. 1989, 6:433-452.